Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.9 USD | +0.46% | -9.05% | -13.27% |
03:42pm | Bristol-Myers Squibb Says European Regulator Recommends Approval of Bladder Cancer Combination Therapy | MT |
02:47pm | Bristol Myers: positive opinion from the CHMP for Opdivo | CF |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company